Digital Data Collection for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to develop a secure method for collecting health data from people with cancer using digital tools. The goal is to explore how this data might aid in understanding cancer diagnosis and treatment responses and to identify factors that could influence cancer risk. Participants may be suitable if they have a cancer diagnosis, are undergoing cancer treatment, or are healthy individuals interested in contributing data. To join, participants need an iPhone to use a specific health app and must be comfortable sharing health information digitally. As an unphased study, this trial offers participants the chance to contribute to groundbreaking research that could enhance cancer care and prevention strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on collecting physiological data rather than altering treatment plans.
What prior data suggests that this method is safe for collecting physiologic information from cancer patients?
Research shows that collecting health data from home using digital tools is generally safe. Studies have found that remote monitoring, such as checking blood pressure and sugar levels at home, is easy for most people. Individuals record their own health information and share it with their doctors, allowing doctors to monitor health without frequent office visits.
The studies reviewed have not identified major safety issues. Remote monitoring is already used in many healthcare settings, indicating it is a safe and trusted method. While any medical process might have some risks, evidence supports the safety of collecting health data from home.12345Why are researchers excited about this trial?
Researchers are excited about the remote digital physiologic data collection method in cancer care because it offers a cutting-edge way to monitor patients outside of traditional clinical settings. Unlike standard treatments that rely heavily on in-person visits and manual data collection, this approach uses digital tools to gather real-time physiological data remotely. This method could lead to more personalized and timely interventions, improving patient outcomes and quality of life by allowing healthcare providers to respond quickly to changes in a patient's condition. Additionally, it has the potential to make healthcare more accessible and convenient by reducing the need for frequent hospital visits.
What evidence suggests that this method is effective for collecting physiologic data in cancer patients?
Research has shown that collecting health data remotely, such as blood pressure and blood sugar levels, can be effective outside traditional healthcare settings. This allows doctors to monitor patients' health in real time without requiring clinic visits. Studies have found that continuous data collection can lead to more personalized treatment plans. While often used for chronic conditions, this method also shows promise for tracking cancer patients' responses to treatment. However, concerns remain about the cost-effectiveness of this technology and its overall impact on healthcare.678910
Who Is on the Research Team?
Luke Pike, MD, DPhil
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Data Collection
Participants' physiological data is collected remotely to study its relation to cancer diagnosis and treatment response
Follow-up
Participants are monitored for safety and effectiveness after data collection
What Are the Treatments Tested in This Trial?
Interventions
- Remote Digital Physiologic Data Collection
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
University of California, Los Angeles
Collaborator